Endo logo

FP&D Director, Sterile Injectables and Global R&D

Endo

Malvern, PA; Hazelwood, MOHybridPosted 1 day ago
Full TimeDirector & AboveCorporate FunctionsPharmaceutical
Original posting ↗

Summary

The primary focus of this position is to provide strategic financial business partnering support to Sterile Injectables and Global Research & Development. The foundational requirements for this role include financial planning, analytical support through robust financial modeling, risk/opportunity analysis, standard and ad hoc financial analytics, as well as expense monitoring, and responsibility for month-end close and control activities. This role will also be responsible for the overall consolidation of management reporting for the assigned function, as well as driving continuous process improvement in planning and analytics, including driving alignment with Par Health's financial systems / IT teams to ensure maximum efficiency and transparency within the forecasting/reporting processes. This Director will also collaborate with Research & Development and Commercial leadership (Sterile and Generics) to manage overall R&D spend, as well as monitoring the R&D Project Portfolio. They will also collaborate with Sterile leadership to optimize performance while protecting the long-term health of the business. The position will serve as the primary liaison with the Corporate FP&A function for recurring monthly/quarterly/annual deliverables.

Job description

Job Description Summary

The primary focus of this position is to provide strategic financial business partnering support to Sterile Injectables and Global Research & Development. The foundational requirements for this role include financial planning, analytical support through robust financial modeling, risk/opportunity analysis, standard and ad hoc financial analytics, as well as expense monitoring, and responsibility for month-end close and control activities. This role will also be responsible for the overall consolidation of management reporting for the assigned function, as well as driving continuous process improvement in planning and analytics, including driving alignment with Par Health's financial systems / IT teams to ensure maximum efficiency and transparency within the forecasting/reporting processes. This Director will also collaborate with Research & Development and Commercial leadership (Sterile and Generics) to manage overall R&D spend, as well as monitoring the R&D Project Portfolio. They will also collaborate with Sterile leadership to optimize performance while protecting the long-term health of the business. The position will serve as the primary liaison with the Corporate FP&A function for recurring monthly/quarterly/annual deliverables.

Key Accountabilities

Performance Management

  • Prepare monthly analytics focused on key performance indicators and financial returns; proactively identify business opportunities/risks and potential mitigating actions to business leaders
  • Responsible for standard monthly management reporting requirements including business/project performance, expense reporting, analysis, and P&L commentary.
  • Support Global Head of Sterile Injectables and R&D, Investor Relations, and Corporate FP&A with quarterly earnings analysis and other data requests
  • Identify and implement continuous improvements in the FP&A team's performance monitoring and management reporting deliverables

Planning & Forecasting

  • Set the annual planning calendar for the business unit in alignment with the Enterprise planning calendar
  • Lead the monthly and annual financial planning and forecasting activities for specific business units and functions within the unit; forecast cycles include Annual Budget, Long-term Strategic Plan, quarterly forecasts and periodic updates (Latest Views)

Leadership Support

  • Support Senior Management with analysis required to present to the Executive team and the Board of Directors, including preparation of Quarterly Business Reviews, Budget/LBE presentations, and Board of Director presentation materials
  • Interface with Senior Leaders to assist with financial planning for key projects/initiatives, balancing portfolio investment needs with short-term and long-term financial goals

Monthly Close & Financial Controls

  • Review and record financial transactions in accordance with Company policy and generally accepted accounting principles (GAAP)
  • Compile, review, analyze and report actual performance versus plan and forecast
  • Ensure all control requirements are met in accordance with Corporate and SOX guidelines

Financial Management Systems

  • Act as a liaison with IT and financial systems & reporting team to ensure design and functionality of financial management system meets requirements to effectively & efficiently monitor performance of the Sterile Injectables business and R&D function
  • Assist FP&A leadership with the development and refinement of planning, budgeting and forecasting tools & processes, including analysis of submitted data

Working Conditions

  • Up to 10% travel

Requirements

  • Financial / Accounting experience with a minimum of 10 years' experience
  • CPA, MBA preferred
  • At least 5-10 years of increasingly responsible financial planning and analysis experience, preferably in the pharmaceutical industry
  • Experience in successfully introducing technology solutions to financial analysis and planning processes and activities
  • Knowledge of One Stream, SAP, and JDEdwards is desired
  • Knowledge of Microsoft office software is required
  • Strong analytical skills coupled with a solid understanding of business dynamics
  • Strong spreadsheet and PowerPoint/presentation skills required
  • Effective communication is necessary with the ability to interface with senior management as well as various functional and finance groups
  • Ability to communicate results of analysis effectively and with impact
  • Ability to communicate factual data and associated risk
  • Ability to design robust, scalable analytical tools and processes

Company overview

Endo is a diversified specialty pharmaceutical company headquartered in Malvern, Pennsylvania, founded in 1997. As a global pharmaceutical manufacturer, Endo develops and markets high-value branded pharmaceutical products across therapeutic areas including urology, men's health, orthopedics, and endocrinology. The company operates as a subsidiary of Endo International plc and has established itself as a leader in both branded and generic pharmaceuticals, with a portfolio of over 200 product families. Endo's mission focuses on helping everyone they serve live their best life through the delivery of life-enhancing therapies. The company maintains manufacturing and research facilities across multiple continents, including the United States, Ireland, Canada, and India, employing approximately 2,100-3,100 professionals globally. In 2025, Endo completed a significant merger with Mallinckrodt Pharmaceuticals, resulting in the creation of two focused standalone companies: Keenova Therapeutics for branded therapeutics and Par Health for generics and sterile injectables.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.